Life exists in motion. CellChorus® provides a high-throughput platform for evaluating how individual cells move, behave and interact.
Joined July 2020
- Tweets 145
- Following 54
- Followers 100
- Likes 325
58 Photos and videos
Pinned Tweet
4 Nov 2024
Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more.
cellchorus.com/news/four-abs…
@sitcancer
2
2
3
539
CellChorus retweeted
28 Jan 2025
Trump’s decision to halt federal virtually all federal grants and loans is lawless, destructive, dangerous, and cruel.
It is illegal.
It is unconstitutional.
It’s nothing less than Project 2025 by another name.
Congress must act.
10,555
5,272
25,070
1,561,209
CellChorus retweeted
8 Oct 2024
CellChorus announced that the company, along with The University of Houston, has been awarded up to $2.5 million in funding. houston.innovationmap.com/un…
1
4
54
CellChorus retweeted
11 Oct 2024
In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More genomeweb.com/business-news/…
2
3
408
CellChorus retweeted
5 Nov 2024
Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology! cellchorus.com/news/four-abs…
1
2
2
242
23 Oct 2024
Congrats to @sunilacharya13, @lab_rezvani & collaborators for publishing in Cancer Discovery how CD28 costimulation enhances CAR-NK cell function! CAR27 NK cells with CD28-based costimulation were ~3x more likely to exhibit serial killing. Learn more:
cellchorus.com/news/cancer-d…
2
15
1,397
7 Oct 2024
💥 @CellChorus and @UHouston received a $2.5 million STTR fast-track award for innovations in AI/ML from the @ncats_nih_gov at @NIH. Learn more:
cellchorus.com/news/cellchor…
#ai #artificialIntelligence #ml #machineLearning #singleCell #singleCellAnalysis @UHEngineering
4
11
7,368
13 Sep 2024
Want to learn how to apply TIMING™ for potency and viability analysis in process development? Meet with us at BioProcess International in Boston Sept 25th 26th.
Already registered? Book a meeting in the conference app:
lnkd.in/g3nu5HHS
@BioProcessIntl @InformaConnect
1
1
66
28 Jun 2024
🚨 @IndeeLabs posted a manuscript that applies TIMING™ data from @CellChorus to show that CAR-T cells manufactured with the Indee platform have superior motility and resistance to activation-induced cell death (AICD).
biorxiv.org/content/10.1101/…
@RBerdeaux @MohsenFathi1993
1
7
9
11,184
28 Jun 2024
- TIMING data showed that individual Hy-CAR-T target seeking. contact dynamics, and target killing were just as robust as Nuc-CAR-T.
- TIMING data showed that Hy-CAR-T were more resistant to activation-induced cell death (AICD) AICD contributes to exhaustion of CAR-T cells.
1
1
75
28 Jun 2024
- TIMING measurements of cell movements during target engagement (synapse) showed that Hy-CAR-Ts maintained significantly more motility than donor-matched Nuc-CAR-T cells. Motility has been linked to strong CAR-T potency and patient response in other studies.
1
52
CellChorus retweeted
10 Jun 2024
Immunotherapy is a powerful tool in fighting cancer, but not all patients respond.
However, a team of cancer researchers has recently discovered a new subset of T cells with the @CELLCHORUS (S21) TIMING platform that could improve outcomes for patients: houston.innovationmap.com/ce…
2
19
79
38,950
CellChorus retweeted
17 May 2024
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
8
23
5,419
25 May 2024
💥Publication alert:
CAR T cells from individuals with complete response were enriched for migration and serial killing. Learn more about the TIMING™ data:
cellchorus.com/news/nature-c…
@NatureCancer @UH_NVLab @MohsenFathi1993 #singleCellAnalysis #CART #cellTherapy
17 May 2024
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
1
3
137
Dynamic functional profiling of T-cell therapies uncover a subset of T cells, labeled CD8-fit, that are motile serial killers and are associated with clinical responses in diffuse B cell lymphoma patients.
nature.com/articles/s43018-0…
(No Paywall) singlecell.chee.uh.edu/wp-co…
3
8
392